361 related articles for article (PubMed ID: 29540406)
1. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
[TBL] [Abstract][Full Text] [Related]
2. 40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland.
Herrmann C; Ess S; Thürlimann B; Probst-Hensch N; Vounatsou P
BMC Cancer; 2015 Oct; 15():666. PubMed ID: 26453319
[TBL] [Abstract][Full Text] [Related]
3. Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.
Fenner L; Kässner A; Berlin C; Egger M; Zwahlen M
Swiss Med Wkly; 2018; 148():w14603. PubMed ID: 29756635
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening in Switzerland: limited evidence from limited data.
Zwahlen M; Bopp M; Probst-Hensch NM
Swiss Med Wkly; 2004 May; 134(21-22):295-306. PubMed ID: 15243841
[TBL] [Abstract][Full Text] [Related]
5. Introduction of an organised programme and social inequalities in mammography screening: A 22-year population-based study in Geneva, Switzerland.
Sandoval JL; Theler JM; Cullati S; Bouchardy C; Manor O; Gaspoz JM; Guessous I
Prev Med; 2017 Oct; 103():49-55. PubMed ID: 28778819
[TBL] [Abstract][Full Text] [Related]
6. Organised population-based programmes and change in socioeconomic inequalities in mammography screening: A 1992-2012 nationwide quasi-experimental study.
Cullati S; von Arx M; Courvoisier DS; Sandoval JL; Manor O; Burton-Jeangros C; Bouchardy C; Guessous I
Prev Med; 2018 Nov; 116():19-26. PubMed ID: 30145347
[TBL] [Abstract][Full Text] [Related]
7. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
[TBL] [Abstract][Full Text] [Related]
8. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.
Iwamoto Y; Kaucher S; Lorenz E; Bärnighausen T; Winkler V
BMC Public Health; 2019 Jun; 19(1):823. PubMed ID: 31242882
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer prevention behaviour: a perspective of women from three language regions of Switzerland].
Glaus A; Fäh B; Hornung R; Senn H; Stiefel F
Pflege; 2004 Dec; 17(6):385-94. PubMed ID: 15648588
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of organised versus opportunistic mammography screening.
Bulliard JL; Ducros C; Jemelin C; Arzel B; Fioretta G; Levi F
Ann Oncol; 2009 Jul; 20(7):1199-202. PubMed ID: 19282467
[TBL] [Abstract][Full Text] [Related]
12. Small-area spatio-temporal analyses of participation rates in the mammography screening program in the city of Dortmund (NW Germany).
Lemke D; Berkemeyer S; Mattauch V; Heidinger O; Pebesma E; Hense HW
BMC Public Health; 2015 Nov; 15():1190. PubMed ID: 26615393
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
[TBL] [Abstract][Full Text] [Related]
14. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
16. Uptake of breast cancer screening measures among immigrant and Swiss women in Switzerland.
Fontana M; Bischoff A
Swiss Med Wkly; 2008 Dec; 138(49-50):752-8. PubMed ID: 19130329
[TBL] [Abstract][Full Text] [Related]
17. Effect of an organised screening program on socioeconomic inequalities in mammography practice, knowledge and attitudes.
Relecom A; Arzel B; Perneger T
Int J Equity Health; 2018 Jul; 17(1):95. PubMed ID: 29970090
[TBL] [Abstract][Full Text] [Related]
18. How effective are breast cancer screening programmes by mammography? Review of the current evidence.
Schopper D; de Wolf C
Eur J Cancer; 2009 Jul; 45(11):1916-23. PubMed ID: 19398327
[TBL] [Abstract][Full Text] [Related]
19. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
20. Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland.
Jürgens V; Ess S; Phuleria HC; Früh M; Schwenkglenks M; Frick H; Cerny T; Vounatsou P
Geospat Health; 2013 May; 7(2):219-36. PubMed ID: 23733286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
